CLOSE

Benchmark Investments

Nippon India Nifty Pharma ETF

very highequityindex
22.39 0.23(1.02%) NAV as on 22 Nov 2024
-3.79 % 1 M
37.15 % 1 Y
18.97 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

0.21

As on 31 Oct, 2024
Age :

3 yrs 4 m

Since 06 07 ,2021
Exit Load :

%

AUM :

852.28 Crs

Portfolio Price To Book Value :

6.62

Investing Style :

Large Growth

Min. Investment :

SIP NA & Lumpsum 1000

Category :

etfs

Fund Manager :

Himanshu Mange

Launch Date :

06-Jul-21

Scheme Benchmark :

NA

FUND OBJECTIVE

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2024
Others 0.05 %
Equity 99.95 %

TOP HOLDINGS

Sun Pharmaceutical Industries...25.08 %
Cipla Ltd.10.71 %
Dr. Reddy's Laboratories Ltd.9.76 %
Divi's Laboratories Ltd.9.39 %
Lupin Ltd.6.62 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs99.95
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)13.6512.1619.32
Net Assets(Rs Crores) (as on 31-Mar-2024) 87.63 197.85 643.07
Scheme Returns(%)(Absolute)-5.25-10.9258.21
B'mark Returns(%)(Absolute)NANANA
Category Rank109/111150/16029/201

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2024-20253.8418.32NANA
2023-202414.5312.509.1113.01
2022-2023-10.467.10-2.90-4.37
2021-2022NANA-1.68-4.27

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Nifty Pharma ETFVery HighEquity22.390.23(1.02%)NAV As on 22 Nov, 202406-Jul-2021Inception Date852.28AUM In Cr.37.15%1Y18.97%3YNA%5Y13.91%Since Inception
Motilal Oswal Nifty Midcap 100 ETFVery HighEquity58.890.68(1.16%)NAV As on 22 Nov, 202403-Feb-2011Inception Date533.70AUM In Cr.31.64%1Y22.63%3Y27.25%5Y15.70%Since Inception
ICICI Pru Nifty 50 ETFVery HighEquity265.576.19(2.38%)NAV As on 22 Nov, 202420-Mar-2013Inception Date20,869.67AUM In Cr.22.01%1Y12.41%3Y16.15%5Y14.34%Since Inception
Aditya Birla SL Nifty 50 ETFVery HighEquity27.460.64(2.38%)NAV As on 22 Nov, 202421-Jul-2011Inception Date2,760.77AUM In Cr.21.97%1Y12.40%3Y16.14%5Y12.74%Since Inception
Nippon India ETF Nifty 50 BeESVery HighEquity266.986.22(2.38%)NAV As on 22 Nov, 202428-Dec-2001Inception Date34,392.26AUM In Cr.22.00%1Y12.39%3Y16.14%5Y15.96%Since Inception
Axis NIFTY 50 ETFVery HighEquity259.466.04(2.38%)NAV As on 22 Nov, 202403-Jul-2017Inception Date684.56AUM In Cr.21.96%1Y12.39%3Y16.11%5Y14.53%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd